Impact of amniotic stem cell-conditioned medium on tear film integrity and MMP-9 levels in canine dry eye syndrome
Experimental Eye Research · 2026
DOI: 10.1016/j.exer.2025.110736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2026. Verfasst von Agnieszka Balicka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Small Animals Clinic, University of Veterinary Medicine and Pharmacy in Košice, Košice, Slovakia. Hauptthemen laut MEDLINE: Tears, Matrix Metalloproteinase 9, Stem Cells, Amnion. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Grant Agency of the MŠVVaŠ and the SAV.
Abstract (Originalsprache)
This study provides the first assessment of eye drops made using conditioned media from amniotic stem cells (AMSCCM), for the treatment of qualitative keratoconjunctivitis sicca (KCS) in dogs. Tear fluid secretion was measured using the Schirmer tear test (STT), and collected samples were analyzed for total protein concentration and matrix metalloproteinase-9 (MMP-9) levels to assess ocular surface inflammation and potential regenerative effects. To evaluate tear film morphology and see structural changes linked to KCS and therapy response, atomic force microscopy (AFM) was used. Results from treatment with AMSCCM-based eye drops were encouraging; 50 % of treated dogs had increased protein levels, decreased MMP-9 expression, and enhanced tear production, all of which suggested anti-inflammatory and restorative effects. These findings lay the groundwork for further exploration of AMSCCM as a novel treatment strategy for canine KCS, particularly in cases unresponsive to conventional therapies. Despite these encouraging findings, further studies should focus on longer treatment durations, optimized dosing regimens, and inclusion of additional diagnostic tools and broader cytokine profiling to fully characterize therapeutic efficacy and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Small Animals Clinic, University of Veterinary Medicine and Pharmacy in Košice, Košice, Slovakia.
- Centre for Experimental and Clinical Regenerative Medicine, Small Animals Clinic, University of Veterinary Medicine and Pharmacy in Košice, Košice, Slovakia.
- Department of Medical and Clinical Biochemistry, Pavol Jozef Šafárik University, Košice, Slovakia.
- Institute of Physical Sciences, Pavol Jozef Šafárik University, Košice, Slovakia; Division of Ceramic and Non-metallic Systems, Institute of Materials Research, Slovak Academy of Sciences, Košice, Slovakia.
- Institute of Physical Sciences, Pavol Jozef Šafárik University, Košice, Slovakia.
- Department of Medical and Clinical Biophysics, Pavol Jozef Šafárik University, Košice, Slovakia.
Förderung
- Scientific Grant Agency of the MŠVVaŠ and the SAV
Zitieren
APA
Balicka, A., Hudáková, N., Lapšanská, M., Rašiová, A., Trbolová, A., Tomečková, V., Kondrakhova, D., Komanický, V., Večurkovská, I., Bober, P., Horňáková, Ľ., Vikartovská, Z., & Cizkova, D. (2026). Impact of amniotic stem cell-conditioned medium on tear film integrity and MMP-9 levels in canine dry eye syndrome. Experimental Eye Research. https://doi.org/10.1016/j.exer.2025.110736
Vancouver
Balicka A, Hudáková N, Lapšanská M, Rašiová A, Trbolová A, Tomečková V, et al. Impact of amniotic stem cell-conditioned medium on tear film integrity and MMP-9 levels in canine dry eye syndrome. Experimental Eye Research. 2026. doi:10.1016/j.exer.2025.110736
BibTeX
@article{Balicka2026,
author = {Balicka, Agnieszka and Hudáková, Nikola and Lapšanská, Mária and Rašiová, Adriána and Trbolová, Alexandra and Tomečková, Vladimíra and Kondrakhova, Dária and Komanický, Vladimír and Večurkovská, Ivana and Bober, Peter and Horňáková, Ľubica and Vikartovská, Zuzana and Cizkova, Dasa},
title = {Impact of amniotic stem cell-conditioned medium on tear film integrity and MMP-9 levels in canine dry eye syndrome},
journal = {Experimental Eye Research},
year = {2026},
doi = {10.1016/j.exer.2025.110736}
}
EUVIMED